Chronic ANG II infusion increases NO generation by rat descending vasa recta

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 288, Issue 1 57-1, 2005, Pages

  Zhang, Zhong ^a   Rhinehart, Kristie ^a   Solis, Glen ^b   Pittner, Janos ^a   Lee Kwon, Whaseon ^a   Welch, William J ^b   Wilcox, Christopher S ^b   Pallone, Thomas L ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

Calcium; Kidney; Medulla; Microcirculation; Oxidative stress

Indexed keywords

3 AMINO 4 AMINOMETHYL 2',7' DIFLUOROFLUORESCEIN; ANGIOTENSIN; FLUORESCEIN; HYDROETHIDINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; CONFERENCE PAPER; CONTROLLED STUDY; DESCENDING VASA RECTA; ENDOTHELIUM; HYPERTENSION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; RENAL ARTERY;

ACETYLCHOLINE; ANGIOTENSIN II; ANIMALS; ARTERIOLES; BIOLOGICAL AVAILABILITY; CALCIUM SIGNALING; CYCLIC N-OXIDES; DRUG ADMINISTRATION SCHEDULE; ENZYME INHIBITORS; ETHIDIUM; INFUSION PUMPS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SPIN LABELS; SUPEROXIDES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 11144307288     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00623.2004     Document Type: Conference Paper

References (46)

1. Carey RM, Jin X, Wang Z, and Siragy HM. Nitric oxide: a physiological mediator of the type 2 (AT2) angiotensin receptor. Acta Physiol Scand 168: 65-71, 2000.
2. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ, and Wilcox CS. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285: R117-R124, 2003.
3. 2 counteracts the vasodilator and natriuretic effects of superoxide dismutation by Tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285: R827-R833, 2003.
4. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
5. Cowley AW Jr, Mori T, Mattson D, and Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 284: R1355-R1369, 2003.
6. Dickhout JG, Mori T, and Cowley AW Jr. Tubulovascular nitric oxide crosstalk: buffering of angiotensin II-induced medullary vasoconstriction. Cire Res 91: 487-493, 2002.
7. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
8. Edgley AJ, Kett MM, and Anderson WP. Evidence for renal vascular remodeling in angiotensin II-induced hypertension. J Hypertens 21: 1401-1406, 2003.
9. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
10. Imig JD. Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension. Am J Hypertens 13: 810-818, 2000.
11. Kawada N, Imai E, Karber A, Welch WJ, and Wilcox CS. A mouse model of angiotensin II slow pressor response: role of oxidative stress. J Am Soc Nephrol 13: 2860-2860, 2002.
12. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, and Griendling KK. Novel gp91(phox) homologues in vascular smooth muscle cells: Nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 88: 888-894, 2001.
13. Li N, Yi FX, Spurrier JL, Bobrowitz CA, and Zou AP. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney, Am J Physiol Renal Physiol 282: F1111-F1119, 2002.
14. Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, and Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to Angiotensin II. Hypertension 33: 1013-1019, 1999.
15. Long DA, Price KL, Herrera-Acosta J, and Johnson RJ. How does angiotensin II cause renal injury? Hypertension 43: 722-723, 2004.
16. 2 leads to hypertension. Hypertension 42: 25-30, 2003.
17. Makino A, Skelton MM, Zou AP, Roman RJ, and Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 39: 667-672, 2002.
18. Melaragno MG and Fink GD. Slow pressor effect of angiotensin II in normotensive rats with renal artery stenosis. Clin Exp Pharmacol Physiol 23: 140-144, 1996.
19. Meng S, Roberts LJ II, Cason GW, Curry TS, and Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 283: R732-R738, 2002.
20. Mori T and Cowley AW Jr. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 42: 588-593, 2003.
21. Ortiz PA and Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol 283: F957-F962, 2002.
22. Pallone TL. Microdissected perfused vessels. Methods Mol Med 86: 443-456, 2003.
23. Pallone TL, Zhang Z, and Rhinehart K. Physiology of the renal medullary microcirculation. Am J Physiol Renal Physiol 284: F253-F266, 2003.
24. Pallone TL, Silldorff EP, and Zhang Z. Inhibition of calcium signaling in descending vasa recta endothelia by ANG II. Am J Physiol Heart Circ Physiol 278: H1248-H1255, 2000.
25. Pelaez LI, Manriquez MC, Nath KA, Romero JC, and Juncos LA. Low-dose angiotensin II enhances pressor responses without causing sustained hypertension. Hypertension 42: 798-801, 2003.
26. 2+ signaling. Am J Physiol Heart Circ Physiol 284: H779-H789, 2003.
27. Rhinehart KL and Pallone TL. Nitric oxide generation by isolated descending vasa recta. Am J Physiol Heart Circ Physiol 281: H316-H324, 2001.
28. Sasser JM, Pollock JS, and Pollock DM. Renal endothelin in chronic angiotensin II hypertension. Am J Physiol Regul Integr Comp Physiol 283: R243-R248, 2002.
29. Schnackenberg CG. Physiological and pathophysiological roles of oxygen radicals in the renal microvasculature. Am J Physiol Regul Integr Comp Physiol 282: R335-R342, 2002.
30. Schnackenberg CG and Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandinF. Hypertension 33: 424-428, 1999.
31. Schnackenberg CG, Welch WJ, and Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 32: 59-64, 1998.
32. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, and Griendling KK. Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators. Circ Res 91: 406-413, 2002.
33. Silldorff EP and Pallone TL. Adenosine signaling in outer medullary descending vasa recta. Am J Physiol Regul Integr Comp Physiol 280: R854-R861, 2001.
34. Siragy HM, Inagami T, Ichiki T, and Carey RM. Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci USA 96: 6506-6510, 1999.
35. Thannickal VJ and Fanburg BL. Reactive oxygen species in cell signaling. Am J Physiol Lung Cell Mol Physiol 279: L1005-L1028, 2000.
36. Touyz RM and Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 34: 976-982, 1999.
37. Wang D, Chabrashvili T, and Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res 94: 1436-1442.
38. Wang D, Chen Y, Chabrashvili T, Aslam S, Borrego Conde LJ, Umans JG, and Wilcox CS. Role of oxidative stress in endothelial dysfunction and enhanced responses to angiotensin II of afferent arterioles from rabbits infused with angiotensin II. J Am Soc Nephrol 14: 2783-2789, 2003.
39. Wang CT, Chin SY, and Navar LG. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 279: F319-F325, 2000.
40. Welch WJ, Baumgartl H, Lubbers D, and Wilcox CS. Renal oxygenation defects in the spontaneously hypertensive rat: role of AT1 receptors. Kidney Int 63: 202-208, 2003.
41. Yang S, Silldorff EP, and Pallone TL. Effect of norepinephrine and acetylcholine on outer medullary descending vasa recta. Am J Physiol Heart Circ Physiol 269: H710-H716, 1995.
42. Zhang Z, Rhinehart K, Lee-Kwon W, Weinman E, and Pallone TL. AngII signaling in vasa recta pericytes by PKC and reactive oxygen species. Am J Physiol Heart Circ Physiol 287: H773-H781, 2004.
43. Zhao H, Kalivendi S, Zhang H, Joseph J, Nithipatikom K, Vasquez-Vivar J, and Kalyanaraman B. Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic Biol Med 34: 1359-1368, 2003.
44. Zou AP and Cowley AW Jr. Nitric oxide in renal cortex and medulla. An in vivo microdialysis study. Hypertension 29: 194-198, 1997.
45. Zou AP, Li N, and Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension 37: 547-553, 2001.
46. Zou AP, Wu F, and Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 31: 271-278, 1998.